AKT1 and neoplasm: EBV-encoded proteins, such as latent membrane protein 1 (LMP1), can activate several oncogenic signaling pathways, including NF-κB and PI3K/AKT, which drive B-cell proliferation, promote genomic instability, and contribute to tumor progression (18).